MedPath

The effect of naloxon, a drug that removes the effect of morfin), on pain hypersensitivity after a inguinal herniotomy operation.

Conditions
First degree burn injury in healthy volunteers who 6-8 weeks prior have had done a Inguinal herniotomy .
MedDRA version: 16.1Level: LLTClassification code 10049475Term: Chronic painSystem Organ Class: 100000004867
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2013-004709-17-DK
Lead Sponsor
Rigshospitalet
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

•Healthy male
•Age ? 18 år og ? 65 years
•Signed informed consent
•Patients submitted to unilateral, primary inguinal, open herniotomy 6-8 weeks prior to study start.
•Open operating procedure a.m. Lichtenstein.
•Urin sample without traces of opioids (morphin, methadon, buprenorphine, codeine, tramadol, ketobemidone, oxycodone, hydromorphone, dextromethorphan)
•ASA I-II
•Body mass index (BMI): 18 < BMI < 30

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 14
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 2

Exclusion Criteria

•Volunteers , who do not speak or understand Danish
•Volunteers, who cannot cooperate with the investigation
•Volunteers, who have had previous surgery in the groin region
•Volunteers with pain at rest > 3 (NRS)
•Activity-related pain in the surgical field > 5 (NRS)
•Allergic reaction against morphine or other opioids (including naloxone),
•Abuse of alcohol or drugs – according to investigator’s evaluation
•Use of psychotropic drugs (exception of SSRI)
•Neurologic or psychiatric disease
•Chronic pain condition
•Regular use of analgesic drugs
•Skin lesions and tattoos in the assessment areas
•Nerve lesions in the assessment sites (for instance, after trauma, disc herniation, etc.)
•Use of prescription drugs one week before the trial
•Use of over-the-counter drugs 48 hours before the trial

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath